在治疗形甲状腺癌的过程中,预后指数的动态
Masaomi Sen1,2, Ryo Ito3, Takeshi Abe3
1Department of Endocrine Surgery, Nippon Medical Musashi Kosugi Hospital, 1-383 Kosugi-cho, Nakahara-ku, Kawasaki-shi, Kanagawa, 211-8533, Japan. m-sen0@nms.ac.jp.
Surgery today
|January 6, 2025
概括
预后指数 (PI) 可以动态跟踪形甲状腺癌 (ATC) 治疗的有效性. 抗胰岛素的变化与患者的存活率相关,有助于对这种侵袭性癌症的治疗决定.
科学领域:
- 在瘤学瘤学.
- 甲状腺癌研究研究
- 生物标志物发现发现
背景情况:
- 无塑性甲状腺癌 (ATC) 阶段和预后指数 (PI) 指导治疗.
- 新疗法需要动态标志物来评估疾病状态和治疗疗效.
研究的目的:
- 评估预后指数 (PI) 作为治疗形甲状腺癌 (ATC) 的动态标记.
- 评估PI在预测ATC的预后和指导治疗决策中的有用性.
主要方法:
- 对20名积极治疗的ATC患者 (2011-2022) 的回顾性研究.
- 患者在治疗前和治疗后分为PI组 (低/高) 的分层.
- 在不同PI类别和变化中比较生存率.
主要成果:
- 在PI组之间观察到显著的生存差异 (p < 0.01).
- 与PI没有下降 (87天) 相比,PI下降的患者的平均整体存活时间更长 (363天).
- 一些最初PI高的患者在治疗期间获得了较低的PI,但有些人随后经历了增加.
结论:
- 预后指数 (PI) 是ATC治疗决策的关键预后指标.
- PI显示出作为ATC疾病状况和治疗反应监测的动态标记物的潜力.
相关概念视频
Tumor Progression
6.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.0K
Cancer Survival Analysis
290
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
290


